Collectively, these findings indicate that hnRNPU is a crucial splicing factor implicated in aberrant AS events in GC, and highly expressed levels of hnRNPU are predictive of an unfavorable prognosis in GC patients. Here, HNRNPU is linked to gastric cancer.